IGF2 and hepatocellular carcinoma: In addition, the loss of the gene imprinting of IGF-2 has also been observed in neoplasms, including hepatic carcinoma, breast carcinoma, lung cancer, cervical cancer, choriocarcinoma, etc., [19,20], which result from the increased expression of IGF-2 in tumors, promoting tumor cell growth.